A state program for prevention of sensitization to Rh factor.
D000917:Antibody Formation; D001782:Blood Donors; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008404:Massachusetts; D010956:Plasmapheresis; D011247:Pregnancy; D011635:Public Health Administration; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use*
D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins